Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients

European Journal of Endocrinology

Volumn 165, Issue 1, 2011, Pages 91-96

  Scholten, Anouk ^a   Vriens, Menno R ^a   Cromheecke, Geert Jan E ^a   Rinkes, Inne H M Borel ^a   Valk, Gerlof D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALECTOMY; ADULT; ARTICLE; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTENSION; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING; TUMOR VOLUME; DISEASE SEVERITY; HEART HEMODYNAMICS; MEAN ARTERIAL PRESSURE; NEUROFIBROMATOSIS; SIPPLE SYNDROME; SURGICAL RISK; SYMPTOM; SYSTOLIC BLOOD PRESSURE; ADRENAL TUMOR; BLOOD PRESSURE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PEROPERATIVE COMPLICATION;

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; METOPROLOL;

ADRENAL GLAND NEOPLASMS; ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADULT; BLOOD PRESSURE; COHORT STUDIES; DOXAZOSIN; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION; INTRAOPERATIVE COMPLICATIONS; MALE; METOPROLOL; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES;

EID: 79959421537     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0148     Document Type: Article

References (26)

1. Desmonts JM & Marty J. Anaesthetic management of patients with phaeochromocytoma. British Journal of Anaesthesia 1984 56 781-789. (doi:10.1093/bja/56.7.781)
2. Bravo EL & Gifford RW. Current concepts. Pheochromocytoma: diagnosis, localization and management. New England Journal of Medicine 1984 311 1298-1303. (doi:10.1056/NEJM198411153112007)
3. Lenders JW, Eisenhofer G, Mannelli M & Pacak K. Phaeochromocytoma. Lancet 2005 366 665-675. (doi:10.1016/S0140-6736(05)67139-5)
4. Lo CY, Lam KY, Wat MS & Lam KS. Adrenal pheochromocytoma remains a frequently overlooked diagnosis. American Journal of Surgery 2000 179 212-215. (doi:10.1016/S0002-9610(00)00296-8)
5. Apgar V & Papper EM. Pheochromocytoma: anestheticmanagement during surgical treatment. Archives of Surgery 1951 62 634-648.
6. Feldman JM, Blalock JA, Fagraeus L, Miller JN, Farrell RE & Wells SA Jr. Alterations in plasma norepinephrine concentration during surgical resection of pheochromocytoma. Annals of Surgery 1978 188 758-768. (doi:10.1097/00000658- 197812000-00008)
7. Kinney MA, Narr BJ & Warner MA. Perioperative management of pheochromocytoma. Journal of Cardiothoracic and Vascular Anesthesia 2002 16 359-369. (doi:10.1053/jcan.2002.124150)
8. Miura Y & Yoshinaga K. Doxazosin: a newly developed, selective alpha 1-inhibitor in the management of patients with pheochromocytoma. American Heart Journal 1988 116 1785-1789. (doi:10.1016/0002-8703(88)90230-X)
9. Shupak RC. Difficult anesthetic management during pheochromocytoma surgery. Journal of Clinical Anesthesia 1999 11 247-250. (doi:10.1016/S0952- 8180(99)00014-8)
10. Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CH, Lange JF, de Herder WW & Kazemier G. Risk factors for hemodynamic instability during surgery for pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 2010 95 678-685. (doi:10.1210/jc.2009-1051)
11. Goldstein RE, O'Neill JA Jr, Holcomb GW III, Morgan WM III, Neblett WW III, Oates JA, Brown N, Nadeau J, Smith B, Page DL, Abumrad NN & Scott HWJr. Clinical experience over 48 years with pheochromocytoma. Annals of Surgery 1999 229 755-764 (discussion 764-6). (doi:10.1097/00000658-199906000-00001)
12. Luo A, Guo X, Yi J, Ren H, Huang Y & Ye T. Clinical features of pheochromocytoma and perioperative anesthetic management. Chinese Medical Journal 2003 116 1527-1531. (Pubitemid 37461671)
13. Van Heerden JA, Sheps SG, Hamberger B, Sheedy PF, Poston JG & ReMine WH. Pheochromocytoma: current status and changing trends. Surgery 1982 91 367-373. (Pubitemid 12143735)
14. Hamilton BP, Landsberg B & Levine RJ. Measurement of urinary epinephrine in screening for pheochromocytoma in multiple endocrine neoplasia type II. American Journal of Medicine 1978 42 2928-2934.
15. Atallah F, Bastide-Heulin T, Soulié M, Crouzil F, Galiana A, Samii K & Virenque C. Haemodynamic changes during retroperitoneoscopic adrenalectomy for phaeochromocytoma. British Journal of Anaesthesia 2001 86 731-733. (doi:10.1093/bja/86.5.731)
16. Prys-Roberts C & Farndon JR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World Journal of Surgery 2002 26 1037-1042. (doi:10.1007/s00268-002-6667-z)
17. Iijima T, Takagi T & Iwao Y. An increased circulating blood volume does not prevent hypotension after phaeochromocytoma resection. Canadian Journal of Anaesthesia 2004 51 212-215. (doi:10.1007/BF03019097)
18. Stenstrom G & Kutti J. The blood volume in phaeochromocytoma patients before and during treatment with phenoxybenzamine. Acta Medica Scandinavica 1985 218 381-387. (doi:10.1111/j.0954-6820.1985.tb08862.x)
19. Weismann D, Fassnacht M, Weinberger F, Hamelmann W, Diehl S, Lorenz K, Baerlehner E, Reincke M, Beuschlein F, Knoefel W, Nies C, Hahner S & Allolio B. Intraoperative haemodynamic stability in patients with phaeochromocytoma - minimally invasive vs conventional open surgery. Clinical Endocrinology 2006 65 352-358. (doi:10.1111/j.1365-2265.2006.02603.x)
20. Plouin PF, Duclos JM, Soppelsa F, Boublil G & Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. Journal of Clinical Endocrinology and Metabolism 2001 86 1480-1486. (doi:10.1210/jc.86.4. 1480)
21. Guerrero MA, Schreinemakers JM, Vriens MR, Suh I, Hwang J, Shen WT, Gosnell J, Clark OH & Duh QY. Clinical spectrum of pheochromocytoma. Journal of the American College of Surgeons 2009 209 727-732. (doi:10.1016/j. jamcollsurg.2009.09.022)
22. Huynh TT, Pacak K, Brouwers FM, Abu-Asab MS, Worrell RA, Walther MM, Elkahloun AG, Goldstein DS, Cleary S & Eisenhofer G. Different expression of catecholamine transporters in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. European Journal of Endocrinology 2005 153 551-563. (doi:10.1530/eje.1.01987)
23. Eisenhofer G, Walther MM, Huynh TT, Li ST, Bornstein SR, Vortmeyer A, Manelli M, Goldstein DS, Linehan WM, Lenders JW & Pacak K. Pheochromocytomas in von Hippel-Lindau syndrome andmultiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. Journal of Clinical Endocrinology and Metabolism 2001 86 1999-2008. (doi:10.1210/jc.86.5.1999)
24. Kinney MA, Warner ME, van Heerden JA, Horlocker TT, Young WF Jr, Schroeder DR, Maxson PM & Warner MA. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesthesia and Analgesia 2000 91 1118-1123.
25. Eisenhofer G, Huynh T, Elkahloun A, Morris JC, Bratslavsky G, Linehan WM, Zhuang Z, Balgley BM, Lee CS, Mannelli M, Lenders JW, Bornstein SR & Pacak K. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma. American Journal of Physiology. Endocrinology and Metabolism 2008 295 E1223-E1233. (doi:10.1152/ajpendo.90591. 2008)
26. Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM, Mannelli M, Friberg P, Grebe SK, Timmers HJ, Bornstein SR & Lenders JW. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocrine-Related Cancer 2010 18 97-111. (doi:10.1677/ERC-10-0211)